Back to Search
Start Over
The Liver in Oncology
- Source :
- Clinics in Liver Disease. 21:697-707
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
-
Abstract
- Gastroenterologists and hepatologists will encounter oncology patients who develop abnormal liver tests, patients with hepatic malignancies, and patients with acute and chronic liver disease who require chemotherapy or immediate evaluation. Chemotherapy can cause liver injury owing to toxic effects or idiosyncratic reactions. Immune checkpoint inhibitors may be associated with autoimmune-mediated liver toxicities. Venoocclusive disease requires immediate evaluation. Nodular regenerative hyperplasia is a chronic progressive disorder. Screening and prophylaxis for reactivation of hepatitis B is important to minimize complications in patients receiving chemotherapy. Patients with metastatic lesions can undergo resection or ablation. Hepatic injury may occur in those receiving radiation-based therapies.
- Subjects :
- Oncology
medicine.medical_specialty
medicine.medical_treatment
Hepatic Veno-Occlusive Disease
Antineoplastic Agents
Autoimmune hepatitis
Medical Oncology
Chronic liver disease
Gastroenterology
03 medical and health sciences
Hepatitis B, Chronic
0302 clinical medicine
Progressive disorder
Neoplasms
Internal medicine
medicine
Humans
In patient
Liver injury
Chemotherapy
Hyperplasia
Hepatology
business.industry
Liver Diseases
Hematopoietic Stem Cell Transplantation
Hepatitis B
medicine.disease
Hepatitis, Autoimmune
Liver
030220 oncology & carcinogenesis
Virus Activation
030211 gastroenterology & hepatology
Chemical and Drug Induced Liver Injury
business
Nodular regenerative hyperplasia
Subjects
Details
- ISSN :
- 10893261
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- Clinics in Liver Disease
- Accession number :
- edsair.doi.dedup.....9cb7b52440d5d04a7720c8db13e3fe9a